Sales Of Radiotherapy Devices Are Expected To Increase 2.1x Over The Forecast Period 2022-2032


The examination report distributed by Fact.MR on the Radiotherapy Devices Market is expected to offer dependable information on different key variables forming the development bend of the market. This report fills in as a rich wellspring of data for key elements, for example, strategy producers, end-use ventures, financial backers, and assessment pioneers. The section represented an extensive offer in the Radiotherapy Devices Market in conjecture period 2022 to 2032.

The offer in this portion accompanies many open doors including fabricating items, appropriation, retail, and showcasing administrations. Broad rounds of essential and a far reaching optional exploration have been utilized by the examiners at Fact.MR to show up at different assessments and projections for Demand of Radiotherapy Devices Market, both at worldwide and provincial levels.

Request Sample

Competitive Landscape

The radiation therapy devices market is highly competitive and consists of a few leading manufacturers of radiotherapy devices.

  • In June 2020, Accuray announced the Cyberknife S7 system, which enables improved accuracy and real-time artificial intelligence powered motion tracking. This radiotherapy device is used to deliver treatments such as stereotactic radiosurgery, and stereotactic body radiation therapy. Cyberknife S7 system is a robotic, non-invasive radiation therapy device that can be used to treat malignant and benign tumours as well as neurologic problems across the body.

Key Takeaways from Market Study

  • Global radiotherapy devices market to top US$ 10 Bn by 2031.
  • Linear accelerator devices projected to reach around US$ 4.5 Bn by 2031.
  • Systemic radiotherapy expected to record above 5% CAGR over the next 10 years.
  • Internal beam radiotherapy systems to reach valuation of US$ 1.2 Bn by 2031.
  • Market in Europe holds global share of more than 50%.
  • Market in South Korea to record 4% CAGR over forecast period of 2021- 2031.

“Higher efficacy of radiotherapy devices, increasing introduction of novel therapies, and rising number of government initiatives for cancer care are major factors expected to drive demand for radiotherapy devices over the coming years,” says a Fact.MR analyst.


Leave a Reply

Related Posts